Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Restaurant Brands International
QSR
|
+$236M |
| 2 |
Corpay
CPAY
|
+$186M |
| 3 |
Humana
HUM
|
+$160M |
| 4 |
DuPont de Nemours
DD
|
+$147M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$341M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$185M |
| 3 |
Westlake Corp
WLK
|
+$162M |
| 4 |
T-Mobile US
TMUS
|
+$153M |
| 5 |
Centene
CNC
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.18% |
| 2 | Technology | 22.82% |
| 3 | Healthcare | 21.03% |
| 4 | Communication Services | 13.36% |
| 5 | Materials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CF Industries
CF
$19.6B
| $1.51M | 0.03% |
55,385
-43,654
| -44% | -$1.62M |
|
227
New Oriental
EDU
$8.88B
| $1.49M | 0.03% |
13,781
-20,511
| -60% | -$2.63M |
|
228
Urban Outfitters
URBN
$6.36B
| $1.49M | 0.03% |
104,709
+68,810
| +192% | +$1.6M |
|
229
CSX Corp
CSX
$95.6B
| $1.49M | 0.03% |
+77,805
| New | +$1.82M |
|
|
TMX
230
DELISTED
Terminix Global Holdings, Inc.
TMX
| $1.48M | 0.03% |
+54,975
| New | +$1.88M |
|
|
ARCE
231
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $1.48M | 0.03% |
+35,064
| New | +$1.74M |
|
232
Western Union
WU
$2.28B
| $1.45M | 0.03% |
+80,107
| New | +$1.96M |
|
233
VEON
VEON
$4.09B
| $1.45M | 0.03% |
38,410
-24,938
| -39% | -$1.37M |
|
|
HTZ
234
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $1.45M | 0.03% |
234,537
-40,442
| -15% | -$547K |
|
235
Petrobras
PBR
$123B
| $1.44M | 0.03% |
261,993
-21,535
| -8% | -$257K |
|
|
BNY
236
Bank of New York Mellon
BNY
$108B
| $1.43M | 0.03% |
+42,530
| New | +$1.79M |
|
|
MNTV
237
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $1.42M | 0.03% |
105,043
-139,447
| -57% | -$2.4M |
|
238
Element Solutions
ESI
$8.6B
| $1.41M | 0.03% |
+168,769
| New | +$1.79M |
|
239
Ryanair
RYAAY
$28.9B
| $1.41M | 0.03% |
66,203
-59,562
| -47% | -$1.88M |
|
240
XPO
XPO
$23.2B
| $1.4M | 0.03% |
83,130
+3,825
| +5% | +$102K |
|
241
Groupon
GRPN
$797M
| $1.4M | 0.03% |
+71,412
| New | +$2.81M |
|
242
W.W. Grainger
GWW
$61.8B
| $1.38M | 0.03% |
+5,535
| New | +$1.64M |
|
|
SHOE
243
Shoe Station Group
SHOE
$420M
| $1.37M | 0.03% |
132,142
-41,650
| -24% | -$655K |
|
244
IDEX
IEX
$17.3B
| $1.37M | 0.03% |
9,907
-2,693
| -21% | -$423K |
|
245
Green Dot
GDOT
$766M
| $1.36M | 0.03% |
53,555
-133,975
| -71% | -$3.86M |
|
246
DHT Holdings
DHT
$3.2B
| $1.36M | 0.03% |
+177,119
| New | +$1.12M |
|
247
Pediatrix Medical
MD
$2.16B
| $1.36M | 0.03% |
+116,506
| New | +$2.4M |
|
248
Molina Healthcare
MOH
$10.5B
| $1.36M | 0.03% |
+9,703
| New | +$1.3M |
|
|
MXIM
249
DELISTED
Maxim Integrated Products
MXIM
| $1.36M | 0.03% |
+27,900
| New | +$1.6M |
|
250
Pool Corp
POOL
$6.83B
| $1.35M | 0.03% |
+6,885
| New | +$1.47M |
|
Similar funds
Lee Ainslie's Q1 2020 Portfolio in Review
As of Q1 2020, Lee Ainslie held 565 positions worth $4.74B, down 31% from $6.87B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Lee Ainslie withdrew a net $525M in Q1 2020, closing 99 positions and reducing 138 holdings. Its most notable exit was Medicines Co, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Lee Ainslie opened a new position in 1Life Healthcare worth $101M.
- Lee Ainslie's largest Q1 2020 buy was 1Life Healthcare: 5,955,185 shares worth $101M.
- Lee Ainslie added most to Restaurant Brands International in Q1 2020, an estimated $236M increase.
- Lee Ainslie's biggest Q1 2020 reduction was Monster Beverage, cutting an estimated $341M.
- Lee Ainslie fully exited Medicines Co in Q1 2020, selling an estimated $185M.
- Lee Ainslie's ten largest holdings make up 49% of its $4.74B portfolio in Q1 2020.
- Lee Ainslie opened 228 new positions and closed 99 in Q1 2020.
- Lee Ainslie's portfolio value fell 31% quarter-over-quarter to $4.74B.
Based on Maverick Capital's 13F filing for Q1 2020, filed 15 May 2020.